No notes needed Kluck, was a reasonably brief interview, but a good one that explains the significance of PromarkerD including the latest Ph2 Janssen results & their business model.
I was having a bit of a look at Abcam this morning, Co out of UK, listed on NASDAQ- this is interesting, large new USA facility to increase manufacturing & R&D capacity, article out on 13/7/2021:
https://www.prnewswire.com/news-releases/abcam-opens-new-us-facility-in-boston-ma-301332406.html
Worth a read.
Ps. @Kluck you obviously love & care for your doggies very much. A walk in nature is a good time to contemplate things.
Ann: Study shows diabetes drug improves PromarkerD risk scores, page-50
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.090(9.18%) |
Mkt cap ! $140.1M | |||
| Open | High | Low | Value | Volume |
| 99.0¢ | $1.07 | 98.0¢ | $279.6K | 277.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 967 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 4899 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |